- Home
- NNAVW vs SRPT Comparison
NNAVW vs SRPT Comparison
Compare NNAVW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNAVW
- SRPT
- Stock Information
- Founded
- NNAVW 2007
- SRPT 1980
- Country
- NNAVW United States
- SRPT United States
- Employees
- NNAVW 96
- SRPT N/A
- Industry
- NNAVW Industrial Machinery/Components
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- NNAVW Industrials
- SRPT Health Care
- Exchange
- NNAVW Nasdaq
- SRPT Nasdaq
- Market Cap
- NNAVW N/A
- SRPT N/A
- IPO Year
- NNAVW N/A
- SRPT 1997
- Fundamental
- Price
- NNAVW $6.25
- SRPT $18.10
- Analyst Decision
- NNAVW
- SRPT Buy
- Analyst Count
- NNAVW 0
- SRPT 25
- Target Price
- NNAVW N/A
- SRPT $64.00
- AVG Volume (30 Days)
- NNAVW 53.1K
- SRPT 7.5M
- Earning Date
- NNAVW 03-12-2025
- SRPT 08-06-2025
- Dividend Yield
- NNAVW N/A
- SRPT N/A
- EPS Growth
- NNAVW N/A
- SRPT N/A
- EPS
- NNAVW N/A
- SRPT N/A
- Revenue
- NNAVW $4,963,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- NNAVW N/A
- SRPT $26.87
- Revenue Next Year
- NNAVW N/A
- SRPT $3.15
- P/E Ratio
- NNAVW N/A
- SRPT N/A
- Revenue Growth
- NNAVW 43.44
- SRPT 59.15
- 52 Week Low
- NNAVW $4.47
- SRPT $16.96
- 52 Week High
- NNAVW $4.70
- SRPT $162.95
- Technical
- Relative Strength Index (RSI)
- NNAVW N/A
- SRPT 18.77
- Support Level
- NNAVW N/A
- SRPT $18.30
- Resistance Level
- NNAVW N/A
- SRPT $22.98
- Average True Range (ATR)
- NNAVW 0.00
- SRPT 1.43
- MACD
- NNAVW 0.00
- SRPT -0.49
- Stochastic Oscillator
- NNAVW 0.00
- SRPT 0.99
About NNAVW NextNav Inc. Warrant
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.